In the last trading session, 0.33 million Aileron Therapeutics Inc (NASDAQ:ALRN) shares changed hands as the company’s beta touched 2.24. With the company’s per share price at $2.17 changed hands at $0.3 or 16.04% during last session, the market valuation stood at $49.84M. ALRN’s last price was a discount, traded about -241.94% off its 52-week high of $7.42. The share price had its 52-week low at $1.61, which suggests the last value was 25.81% up since then. When we look at Aileron Therapeutics Inc’s average trading volume, we note the 10-day average is 0.12 million shares, with the 3-month average coming to 79.29K.
Aileron Therapeutics Inc (NASDAQ:ALRN) trade information
Instantly ALRN was in green as seen at the end of in last trading. With action 19.79%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -24.56%, with the 5-day performance at 19.79% in the green. However, in the 30-day time frame, Aileron Therapeutics Inc (NASDAQ:ALRN) is -6.88% down. Looking at the short shares, we see there were 0.23 million shares sold at short interest cover period of 3.47 days.
Aileron Therapeutics Inc (ALRN) estimates and forecasts
Data shows that the Aileron Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -20.96% over the past 6 months, a 51.25% in annual growth rate that is considerably higher than the industry average of 16.70%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 39.67%. The 2024 estimates are for Aileron Therapeutics Inc earnings to increase by 54.53%, but the outlook for the next 5-year period is at 2.10% per year.
ALRN Dividends
Aileron Therapeutics Inc is expected to release its next quarterly earnings report in January.
Aileron Therapeutics Inc (NASDAQ:ALRN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.65% of Aileron Therapeutics Inc shares while 28.47% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 28.66%. There are 28.47% institutions holding the Aileron Therapeutics Inc stock share, with HEXAGON CAPITAL PARTNERS LLC the top institutional holder. As of 2024-06-30, the company held 0.0026% of the shares, roughly 213.0 ALRN shares worth $591.0.
